Regulatory News
Monday, July 18, 2016
BRIEF-ANI Pharmaceuticals announces FDA approval, launch of Nilutamide tablets
* ANI Pharmaceuticals announces FDA approval and immediate
launch of Nilutamide tablets, the first generic competitor to
Nilandron
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment